A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Merck Sharp & Dohme LLC
- Study ID
- NCT07677163
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Interventions
- MK-1403 formulation (FM) 1 + additive — DRUGOral tablet
- MK-1403 FM2 + additive — DRUGOral tablet
Study Details
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.
Key Dates
- First listed
- Jun 30, 2026
- Start date
- Aug 14, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 22, 2026
- Completion
- Sep 22, 2026
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: MK-1403 formulation (FM) 1 + additive, FedMK-1403 FM 1 + additive tablet administered once orally at study dose after a high-fat meal.
- Experimental: MK-1403 FM1 + additive, FastedMK-1403 FM1 + additive tablet administered once orally at study dose in a fasted state.
- Experimental: MK-1403 FM2 + additive, FedMK-1403 FM2 tablet + additive administered once orally at study dose after a high-fat meal.
Primary Outcome Measure
Number of Participants Who Experience an Adverse Event (AE) [ Time Frame: Up to approximately 4 weeks ]
Central Contacts
- Toll Free Number1-888-577-8839
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Qps-Mra, Llc | Miami | Florida | 33143 | Study Coordinator |
Find similar trials in Miami, FL
Related Studies
- Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated DonorsPHASE3 · Recruiting · Center for International Blood and Marrow Transplant Research · Boca Raton, Florida
- Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss OutcomeEnrolling By Invitation · Mayo Clinic · Jacksonville, Florida
- Breathing & Blood PressureRecruiting · Florida State University · Tallahassee, Florida
- A Study of Renal Microvessel Imaging for Chronic Kidney DiseasePHASE2 · Enrolling By Invitation · Mayo Clinic · Jacksonville, Florida